MedTrace Logo

Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning Hair

NCT07041489 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2025-06-27

No results posted yet for this study

Summary

The goal of this clinical trial is to test how safe and effective it is to improve hair growth using an active gummy and serum combination treatment when compared to an inactive treatment combination in women with self-perceived thinning hair.

The main questions this trial aims to answer are:

* to confirm using photograph analytics, how much hair growth has increased in a marked area when using active treatment versus inactive treatment, and
* participants assessment and satisfaction with the hair growth using scaled assessments.

Participants who qualify will be asked to complete 6 to 7 visits after voluntarily consent has been given. The study is divided into two parts. In Part A participants will be randomly given either active or inactive treatment to use over 3 months. After 3 months, all participants will enter Part B of the study and will be given active treatment to use over the final 6 months of the study.

Conditions

  • Hair Thinning

Interventions

DIETARY_SUPPLEMENT

Active Comparator- Xtressé™ Supplement and Serum

Participants will receive 3 month supplies 3 times during the study. Participants will apply serum and take supplements daily. Participants in the Intervention group will receive Xtressé™ Supplements and Serum in Part A and Part B of the study. Participants in the Placebo Group will receive Xtressé™ Supplement and Serum in Part B of the study only.

DIETARY_SUPPLEMENT

Placebo Comparator- Placebo Supplement and Serum

Participants will receive 3 month supplies 3 times during the study. Participants will apply serum and take supplements daily. Participants in the Placebo Group will receive Placebo Supplement and Serum in Part A of the study only.

Sponsors & Collaborators

  • Restore Biologics Holdings, Inc. dba Xtressé

    collaborator INDUSTRY

  • Xtressé (TM)

    collaborator UNKNOWN

  • The Center for Clinical and Cosmetic Research

    lead OTHER

Principal Investigators

  • Danielle Leavitt · Restore Biologics Holdings, Inc. dba Xtressé

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
28 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-20
Primary Completion
2026-03-20
Completion
2026-03-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07041489 on ClinicalTrials.gov